|
CN1072649C
(zh)
|
1995-09-13 |
2001-10-10 |
武田药品工业株式会社 |
苯并氧杂吖庚因化合物,其生产方法和用途
|
|
US6432947B1
(en)
|
1997-02-19 |
2002-08-13 |
Berlex Laboratories, Inc. |
N-heterocyclic derivatives as NOS inhibitors
|
|
AU2610899A
(en)
*
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
N-terminally modified glp-1 derivatives
|
|
EP1137667B1
(en)
*
|
1998-12-07 |
2004-11-17 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Analogues of glp-1
|
|
CN1364167A
(zh)
|
1999-02-26 |
2002-08-14 |
阿瑞那制药公司 |
G蛋白偶联受体6的小分子调节剂
|
|
EP1235618A2
(en)
|
1999-09-07 |
2002-09-04 |
Conjuchem, Inc. |
Bioconjugation in vivo to pulmonary or blood components
|
|
EP1302462A4
(en)
|
2000-07-17 |
2007-07-18 |
Takeda Pharmaceutical |
SULFONATE DERIVATIVES, PROCESS FOR PRODUCTION AND USE THEREOF
|
|
BR0315815A
(pt)
|
2002-11-01 |
2005-09-13 |
Takeda Pharmaceutical |
Agentes para prevenir ou tratar neuropatia, para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor, neuroprotetor e farmacêutico, composto, métodos para prevenir ou tratar neuropatia e para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor para proteger um nervo em um mamìfero e para produzir um composto e uso de um composto
|
|
AU2003277576A1
(en)
|
2002-11-08 |
2004-06-07 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
|
US20070004736A1
(en)
|
2002-11-22 |
2007-01-04 |
Keiji Kubo |
Imidazole derivative, process for producing the same, and use
|
|
WO2004067548A2
(en)
|
2003-01-31 |
2004-08-12 |
Theratechnologies Inc. |
Chemically modified metabolites of regulatory peptides and methods of producing and using same
|
|
US7820837B2
(en)
|
2003-05-30 |
2010-10-26 |
Takeda Pharmaceutical Company Limited |
Condensed ring compound
|
|
EP1670515A2
(en)
|
2003-09-19 |
2006-06-21 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
EP1669352A4
(en)
|
2003-09-30 |
2008-12-17 |
Takeda Pharmaceutical |
THIAZOLINE DERIVATIVE AND ITS USE
|
|
WO2005058823A1
(ja)
|
2003-12-17 |
2005-06-30 |
Takeda Pharmaceutical Company Limited |
ウレア誘導体、その製造法及び用途
|
|
US7456218B2
(en)
|
2003-12-25 |
2008-11-25 |
Takeda Pharmaceutical Company Limited |
3-(4-benzyloxyphenyl) propanoic acid derivatives
|
|
WO2005063725A1
(ja)
|
2003-12-26 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
フェニルプロパン酸誘導体
|
|
WO2005087710A1
(ja)
|
2004-03-15 |
2005-09-22 |
Takeda Pharmaceutical Company Limited |
アミノフェニルプロパン酸誘導体
|
|
JP4859665B2
(ja)
|
2004-03-30 |
2012-01-25 |
武田薬品工業株式会社 |
アルコキシフェニルプロパン酸誘導体
|
|
TWI396686B
(zh)
|
2004-05-21 |
2013-05-21 |
Takeda Pharmaceutical |
環狀醯胺衍生物、以及其製品和用法
|
|
US20060275288A1
(en)
|
2005-01-20 |
2006-12-07 |
Grihalde Nelson D |
GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
|
|
US8957070B2
(en)
|
2005-04-20 |
2015-02-17 |
Takeda Pharmaceutical Company Limited |
Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
|
|
CA2607566A1
(en)
|
2005-05-06 |
2006-11-16 |
Bayer Pharmaceuticals Corporation |
Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
|
|
EP1916234B1
(en)
|
2005-07-29 |
2014-11-12 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
|
US20090054435A1
(en)
|
2005-07-29 |
2009-02-26 |
Hiroshi Imoto |
Phenoxyalkanoic Acid Compound
|
|
JP4094660B1
(ja)
|
2005-08-10 |
2008-06-04 |
武田薬品工業株式会社 |
糖尿病治療剤
|
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
CN101420941A
(zh)
*
|
2006-04-11 |
2009-04-29 |
艾尼纳制药公司 |
Gpr119受体激动剂用于增加骨质量和用于治疗骨质疏松症的用途,和其相关组合疗法
|
|
AU2007265966B2
(en)
|
2006-06-27 |
2012-05-17 |
Takeda Pharmaceutical Company Limited |
Fused cyclic compounds
|
|
JP5399244B2
(ja)
|
2006-08-17 |
2014-01-29 |
アミリン・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー |
選択可能な特性を持つdpp−iv耐性gipハイブリッドポリペプチド
|
|
EP2298772A1
(en)
|
2006-10-18 |
2011-03-23 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds
|
|
CN101573357B
(zh)
|
2006-10-19 |
2013-01-23 |
武田药品工业株式会社 |
吲哚化合物
|
|
WO2008093639A1
(ja)
|
2007-01-29 |
2008-08-07 |
Takeda Pharmaceutical Company Limited |
ピラゾール化合物
|
|
AU2008215490A1
(en)
|
2007-02-09 |
2008-08-21 |
Takeda Pharmaceutical Company Limited |
Fused ring compounds as partial agonists of PPAR-gamma
|
|
JPWO2008136428A1
(ja)
|
2007-04-27 |
2010-07-29 |
武田薬品工業株式会社 |
含窒素5員複素環化合物
|
|
EP2157859A4
(en)
|
2007-06-19 |
2011-01-12 |
Takeda Pharmaceutical |
INDAZOL COMPOUNDS FOR THE ACTIVATION OF GLUCCOKINASE
|
|
ES2558842T3
(es)
|
2008-06-17 |
2016-02-09 |
Indiana University Research And Technology Corporation |
Agonistas mixtos a base de GIP para el tratamiento de trastornos metabólicos y obesidad
|
|
TW201006821A
(en)
*
|
2008-07-16 |
2010-02-16 |
Bristol Myers Squibb Co |
Pyridone and pyridazone analogues as GPR119 modulators
|
|
US20120148586A1
(en)
|
2009-08-27 |
2012-06-14 |
Joyce Ching Tsu Chou |
Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
|
|
US8426414B2
(en)
|
2009-10-09 |
2013-04-23 |
Bristol-Myers Squibb Company |
Modulators of G protein-coupled receptor 88
|
|
KR20120123443A
(ko)
|
2010-01-27 |
2012-11-08 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
대사 장애 및 비만 치료용 글루카곤 길항제-gip 항진제 콘쥬게이트
|
|
US20120021979A1
(en)
|
2010-06-24 |
2012-01-26 |
Vanderbilt University |
GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction
|
|
US20150087586A1
(en)
|
2012-03-29 |
2015-03-26 |
Cebix, Inc. |
Pegylated c-peptide
|
|
CN104884056A
(zh)
*
|
2012-11-12 |
2015-09-02 |
雷德伍德生物科技股份有限公司 |
用于制备缀合物的化合物和方法
|
|
JP6548579B2
(ja)
|
2012-12-06 |
2019-07-24 |
ヴィクトリア リンク リミテッド |
コンジュゲート化合物
|
|
US9766239B2
(en)
|
2013-03-13 |
2017-09-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Synbodies for detection of human norovirus
|
|
CN105555756B
(zh)
|
2013-06-28 |
2018-12-07 |
奥克兰联合服务有限公司 |
氨基酸缀合物和肽缀合物及缀合方法
|
|
WO2015031268A1
(en)
|
2013-08-26 |
2015-03-05 |
Arizona Board Of Regents On Behalf Of Arizona State University |
High affinity synbodies for influenza
|
|
EP3218414A1
(en)
*
|
2014-11-14 |
2017-09-20 |
Angiochem Inc. |
Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin
|
|
WO2016131893A1
(en)
|
2015-02-18 |
2016-08-25 |
Medimmune Limited |
Incretin fusion polypeptides
|
|
CN105219802A
(zh)
*
|
2015-10-10 |
2016-01-06 |
广西大学 |
胰岛组织特异性表达GIPRdn慢病毒载体及其应用
|
|
GB2551945B
(en)
|
2015-12-18 |
2021-09-08 |
Heptares Therapeutics Ltd |
Novel GLP-1 receptor agonist peptides
|
|
MX2020009950A
(es)
*
|
2018-03-23 |
2021-04-28 |
Carmot Therapeutics Inc |
Moduladores de receptores acoplados a proteina g.
|